According to a new study published in Science, fewer women hold biomedical patents, leading to a reduced number of patented technologies designed to address problems affecting women.

Methane is not only a powerful greenhouse gas, but also a source of energy. Microorganisms therefore use it for their metabolism. They do so much more frequently and in more ways than was previously assumed, as revealed by a study now published in Nature Microbiology by researchers from the Max Planck Institute for Marine Microbiology and Jiao Tong University in Shanghai.

MIT researchers have observed a seemingly implausible mode of heat transport, known as “second sound,” in a rather commonplace material: graphite — the stuff of pencil lead. At temperatures of -153°C, they saw clear signs that heat can travel through graphite in a wavelike motion.

German biopharmaceutical company Biontech announced plans for the development of the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022.

Conventional methods for stimulating a specific brain region are highly invasive because they have to insert probes into a target brain. A Kaist research team developed a lightweight capacitive micromachined ultrasonic transducer (CMUT) and succeeded in the ultrasound brain stimulation of a freely-moving mouse.

Researchers at Aalto University have used lignin, a natural polymer abundant in wood and other plant sources, to create a safe, low-cost and high-performing coating for use in construction.

The life science group Sartorius and Brain Biotech intend to jointly research novel CRISPR-Cas genome editing nucleases. The goal is to find suitable solutions for specific applications in the life sciences sector.

The European Commission published an interactive map showcasing Covid-19 vaccine production capacities in the EU, along the entire supply chain.

By acquiring Xell, Sartorius is further expanding its cell culture media business with a focus on media for gene therapies and vaccines. In this way, the Group is primarily expanding its capacities for the production of powder and liquid media.

Scientists have developed a low-cost, CRISPR-based platform that uses saliva samples to diagnose specific Covid-19 variants within just one hour.